ArticleThoracic cancer2020

Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.

Shinnosuke Takemoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.